Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Das S, Stamnaes J, Høydahl LS, Skagen C, Lundin KEA, Jahnsen J, Sollid LM, Iversen R(2024) Selective activation of naïve B cells with unique epitope specificity shapes autoantibody formation in celiac disease J Autoimmun, 146, 103241(in press) DOI 10.1016/j.jaut.2024.103241, PubMed 38754235
Nordberg LB, Pohl H, Haavardsholm EA, Lillegraven S, Bretthauer M(2024) Carbon-Footprint Analyses in RCTs - Toward Sustainable Clinical Practice N Engl J Med(in press) DOI 10.1056/NEJMp2402018, PubMed 38749030
Deneke T, Kutyifa V, Hindricks G, Sommer P, Zeppenfeld K, Carbuccichio C, Pürerfellner H, Heinzel FR, Traykov VB, De Riva M, Pontone G, Lehmkuhl L, Haugaa K(2024) Pre- and Post-Procedural Cardiac Imaging (CT and MRI) in Electrophysiology: A Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) and European Association of Cardiovascular Imaging (EACVI) of the ESC Europace(in press) DOI 10.1093/europace/euae108, PubMed 38743765